Market News
Thursday, June 30, 2016
BRIEF-Valeant Pharmaceuticals announces new licensing arrangement for Brodalumab in Europe
July 1 (Reuters) - Valeant Pharmaceuticals International Inc
:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment